Author:
Wu Chyuan-Chuan,Baiga Thomas J.,Downes Michael,La Clair James J.,Atkins Annette R.,Richard Stephane B.,Fan Weiwei,Stockley-Noel Theresa A.,Bowman Marianne E.,Noel Joseph P.,Evans Ronald M.
Abstract
The peroxisome proliferator-activated receptor (PPAR) family comprises three subtypes: PPARα, PPARγ, and PPARδ. PPARδ transcriptionally modulates lipid metabolism and the control of energy homeostasis; therefore, PPARδ agonists are promising agents for treating a variety of metabolic disorders. In the present study, we develop a panel of rationally designed PPARδ agonists. The modular motif affords efficient syntheses using building blocks optimized for interactions with subtype-specific residues in the PPARδ ligand-binding domain (LBD). A combination of atomic-resolution protein X-ray crystallographic structures, ligand-dependent LBD stabilization assays, and cell-based transactivation measurements delineate structure–activity relationships (SARs) for PPARδ-selective targeting and structural modulation. We identify key ligand-induced conformational transitions of a conserved tryptophan side chain in the LBD that trigger reorganization of the H2′–H3 surface segment of PPARδ. The subtype-specific conservation of H2′–H3 sequences suggests that this architectural remodeling constitutes a previously unrecognized conformational switch accompanying ligand-dependent PPARδ transcriptional regulation.
Funder
Howard Hughes Medical Institute
National Science Foundation
HHS | National Institutes of Health
Foundation for the National Institutes of Health
Leona M. and Harry B. Helmsley Charitable Trust
Publisher
Proceedings of the National Academy of Sciences
Cited by
58 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献